TNFAIP3 haploinsufficiency is the cause of autoinflammatory manifestations in a patient with a deletion of 13Mb on chromosome 6

TNFAIP3 haploinsufficiency is the cause of autoinflammatory manifestations in a patient with a deletion of 13Mb on chromosome 6

Copyright © 2018 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 191(2018) vom: 15. Juni, Seite 44-51
1. Verfasser: Franco-Jarava, Clara (VerfasserIn)
Weitere Verfasser: Wang, Hongying, Martin-Nalda, Andrea, Alvarez, de la Sierra Daniel, García-Prat, Marina, Bodet, Domingo, García-Patos, Vicenç, Plaja, Alberto, Rudilla, Francesc, Rodriguez-Sureda, Victor, García-Latorre, Laura, Aksentijevich, Ivona, Colobran, Roger, Soler-Palacín, Pere
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Case Reports Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Autoinflammatory diseases Behçet’s disease Chromosome deletion Comparative Genomic Hybridization (CGH) Oral ulcer TNFAIP3 mehr... NF-kappa B TNFAIP3 protein, human EC 3.4.19.12 Tumor Necrosis Factor alpha-Induced Protein 3
LEADER 01000naa a22002652 4500
001 NLM282275770
003 DE-627
005 20231225033542.0
007 cr uuu---uuuuu
008 231225s2018 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2018.03.009  |2 doi 
028 5 2 |a pubmed24n0940.xml 
035 |a (DE-627)NLM282275770 
035 |a (NLM)29572183 
035 |a (PII)S1521-6616(18)30122-0 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Franco-Jarava, Clara  |e verfasserin  |4 aut 
245 1 0 |a TNFAIP3 haploinsufficiency is the cause of autoinflammatory manifestations in a patient with a deletion of 13Mb on chromosome 6 
264 1 |c 2018 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 05.07.2019 
500 |a Date Revised 05.07.2019 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2018 Elsevier Inc. All rights reserved. 
520 |a There is scarce literature about autoinflammation in syndromic patients. We describe a patient who, in addition to psychomotor and growth delay, presented with fevers, neutrophilic dermatosis, and recurrent orogenital ulcers. Comparative Genomic Hybridization (CGH) array permitted to identify a 13.13Mb deletion on chromosome 6, encompassing 53 genes, and including TNFAIP3 gene (A20). A20 is a potent inhibitor of the NF-kB signalling pathway and restricts inflammation via its deubiquitinase activity. Western blotting and immunoprecipitation assays showed decreased A20 expression and increased phosphorylation of p65 and IkBa. Patient's cells displayed increased levels of total K63-linked ubiquitin and increased levels of ubiquitinated RIP and NEMO after stimulation with TNF. We describe the molecular characterization of an autoinflammatory disease due to a large chromosomal deletion and review the phenotypes of patients with A20 haploinsufficiency. CGH arrays should be the first diagnostic method for comprehensive analysis of patients with syndromic features and immune dysregulation 
650 4 |a Case Reports 
650 4 |a Journal Article 
650 4 |a Research Support, N.I.H., Intramural 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a Autoinflammatory diseases 
650 4 |a Behçet’s disease 
650 4 |a Chromosome deletion 
650 4 |a Comparative Genomic Hybridization (CGH) 
650 4 |a Oral ulcer 
650 4 |a TNFAIP3 
650 7 |a NF-kappa B  |2 NLM 
650 7 |a TNFAIP3 protein, human  |2 NLM 
650 7 |a EC 3.4.19.12  |2 NLM 
650 7 |a Tumor Necrosis Factor alpha-Induced Protein 3  |2 NLM 
650 7 |a EC 3.4.19.12  |2 NLM 
700 1 |a Wang, Hongying  |e verfasserin  |4 aut 
700 1 |a Martin-Nalda, Andrea  |e verfasserin  |4 aut 
700 1 |a Alvarez, de la Sierra Daniel  |e verfasserin  |4 aut 
700 1 |a García-Prat, Marina  |e verfasserin  |4 aut 
700 1 |a Bodet, Domingo  |e verfasserin  |4 aut 
700 1 |a García-Patos, Vicenç  |e verfasserin  |4 aut 
700 1 |a Plaja, Alberto  |e verfasserin  |4 aut 
700 1 |a Rudilla, Francesc  |e verfasserin  |4 aut 
700 1 |a Rodriguez-Sureda, Victor  |e verfasserin  |4 aut 
700 1 |a García-Latorre, Laura  |e verfasserin  |4 aut 
700 1 |a Aksentijevich, Ivona  |e verfasserin  |4 aut 
700 1 |a Colobran, Roger  |e verfasserin  |4 aut 
700 1 |a Soler-Palacín, Pere  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 191(2018) vom: 15. Juni, Seite 44-51  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:191  |g year:2018  |g day:15  |g month:06  |g pages:44-51 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2018.03.009  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 191  |j 2018  |b 15  |c 06  |h 44-51